Y. Hekmatshoar Et Al. , "Effects of OCT4, SOX2 and NANOG expression on imatinib resistance in CML.," FEBS-EMBO , Paris, France, pp.224, 2014
Hekmatshoar, Y. Et Al. 2014. Effects of OCT4, SOX2 and NANOG expression on imatinib resistance in CML.. FEBS-EMBO , (Paris, France), 224.
Hekmatshoar, Y., Özkan, T., Altınok Güneş, B., Karadağ, A., & Sunguroğlu, A., (2014). Effects of OCT4, SOX2 and NANOG expression on imatinib resistance in CML. . FEBS-EMBO (pp.224). Paris, France
Hekmatshoar, Yalda Et Al. "Effects of OCT4, SOX2 and NANOG expression on imatinib resistance in CML.," FEBS-EMBO, Paris, France, 2014
Hekmatshoar, Yalda Et Al. "Effects of OCT4, SOX2 and NANOG expression on imatinib resistance in CML.." FEBS-EMBO , Paris, France, pp.224, 2014
Hekmatshoar, Y. Et Al. (2014) . "Effects of OCT4, SOX2 and NANOG expression on imatinib resistance in CML.." FEBS-EMBO , Paris, France, p.224.
@conferencepaper{conferencepaper, author={Yalda Hekmatshoar Et Al. }, title={Effects of OCT4, SOX2 and NANOG expression on imatinib resistance in CML.}, congress name={FEBS-EMBO}, city={Paris}, country={France}, year={2014}, pages={224} }